Details

Autor(en) / Beteiligte

• Williams, Nicholas P
• Ostridge, Kristoffer
• Devaster, Jeanne-Marie
• Kim, Viktoriya
• Coombs, Ngaire A
• Bourne, Simon
• Clarke, Stuart C
• Harden, Stephen
• Abbas, Ausami
• Aris, Emmanuel
• Lambert, Christophe
• Tuck, Andrew
• Williams, Anthony
• Wootton, Stephen
• Staples, Karl J
• Wilkinson, Tom M A

Titel

Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD

Ist Teil von

• Respiratory research, 2018-07, Vol.19 (1), p.143-143, Article 143

Ort / Verlag

England: BioMed Central Ltd

Erscheinungsjahr

2018

Link zum Volltext

Quelle

SpringerLink_现刊

Beschreibungen/Notizen

• COPD patients have increased risk of developing pneumonia, which is associated with poor outcomes. It can be symptomatically indistinguishable from exacerbations, making diagnosis challenging. Studies of pneumonia in COPD have focused on hospitalised patients and are not representative of the ambulant COPD population. Therefore, we sought to determine the incidence and aetiology of acute exacerbation events with evidence of pneumonic radiographic infiltrates in an outpatient COPD cohort. One hundred twenty-seven patients with moderate to very severe COPD aged 42-85 years underwent blood and sputum sampling over one year, at monthly stable visits and within 72 h of exacerbation symptom onset. 343 exacerbations with chest radiographs were included. 20.1% of exacerbations had pneumonic infiltrates. Presence of infiltrate was highly seasonal (Winter vs summer OR 3.056, p = 0.027). In paired analyses these exacerbation events had greater increases in systemic inflammation. Bacterial detection rate was higher in the pneumonic group, with Haemophilus influenzae the most common bacteria in both radiological groups. Viral detection and sputum microbiota did not differ with chest radiograph appearance. In an outpatient COPD cohort, pneumonic infiltrates at exacerbation were common, and associated with more intense inflammation. Bacterial pathogen detection and lung microbiota were not distinct, suggesting that exacerbations and pneumonia in COPD share common infectious triggers and represent a continuum of severity rather than distinct aetiological events. Trial registration Number: NCT01360398 .